Prognostic impact of adenylyl cyclase-associated protein 2 (CAP2) in glioma: A clinicopathological study.

Saker, Zahraa; Bahmad, Hisham F; Fares, Youssef; Al Najjar, Zahraa; Saad, Mohamad; Harati, Hayat; Nabha, Sanaa

Saker, Zahraa; Bahmad, Hisham F; Fares, Youssef; Al Najjar, Zahraa; Saad, Mohamad; Harati, Hayat; Nabha, Sanaa.

Afiliação

Saker Z; Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Bahmad HF; Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Fares Y; Department of Anatomy, Cell Biology, and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Al Najjar Z; Faculty of Medicine, Beirut Arab University, Beirut, Lebanon.
Saad M; Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Harati H; Department of Neurosurgery, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
Nabha S; Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.

Heliyon ; 6(1): e03236, 2020 Jan.

Article em En | MEDLINE | ID: mdl-32042970

Palavras-chave

CAP2; Cancer research; Extracellular matrix; Gliomas; Nervous system; Neurology; Oncology; Overexpression; Pathology; Prognostic biomarker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Heliyon Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google